By no means was I trying to downplay any possible uptick.
I just think PharmaCyte investors are all in. The majority has known about this development for years now. And of course big pharma is absolutely aware of it.
Our therapy development is widely known. Even the cancer organizations are watching and waiting.
We're all watching and waiting. And we all have our own reasons why we are. Some want to see the unmet need be successfully addressed and met, and some just want that lucrative exit.
Nevertheless, the point I was trying to make is that the "novelty" may work for new investors, but it won't for us, we're beyond that. And besides, the ONLY thing that will move the pps is completing the work and the submission blessing, PERIOD!
I just got ticked off by the way they just come barging in here the way they did. Come blazing in all at once with a wacked PR in hand, hooping and hollering, hoping to gin up some new investors, but to no avail. Hence, no increase in price, no increase in volume.